Onconova Therapeutics Inc. named Richard Woodman as chief medical officer and senior vice president of research and development.
Woodman was most recently with Novartis AG as senior vice president and head of U.S. oncology clinical development and medical affairs. Prior to that, he was Novartis Oncology's franchise head for hematology in global medical affairs.
Newtown, Pa.-based is a biopharmaceutical company focused on the discovery and development of small molecule drug candidates to treat cancer.
